Industry benchmarks for cell line development timelines
11 Sept 2026Cell line development is a critical part of bringing biological therapeutics to the clinic, but the time and resources required can vary according to the molecule, workflow and level of evidence needed for clone selection.
This whitepaper presents findings from extensive surveys of BioPhorum member companies, covering three stages of a typical cell line development workflow: pre-transfection, transfection and pool selection, and single-cell cloning and lead clone selection. Drawing on 341 questions answered by an average of 27 participating companies, the authors compare timelines, activities, and challenges associated with antibody and complex-molecule programmes.
Explore industry benchmarks for developing CHO production cell lines and understand how data requirements, platform choices, and risk tolerance can influence the route to a lead clone.
Resource details:
Resource type: Whitepaper
Page count: 14 pages
Read time: 21 mins